Regular Article
Metabotropic Glutamate Receptors and Cell-Type-Specific Vulnerability in the Striatum: Implication for Ischemia and Huntington's Disease

https://doi.org/10.1006/exnr.1999.7092Get rights and content

Abstract

Differential sensitivity to glutamate has been proposed to contribute to the cell-type-specific vulnerability observed in neurological disorders affecting the striatum such as Huntington's disease (HD) and global ischemia. Under these pathological conditions striatal spiny neurons are selectively lost while large aspiny (LA) cholinergic interneurons are spared. We studied the electrophysiological effects of metabotropic glutamate receptor (mGluR) activation in striatal spiny neurons and LA interneurons in order to define the role of these receptors in the pathophysiology of the striatum. DCG-IV and l-SOP, agonists for group II and III mGluRs respectively, produced a presynaptic inhibitory effect on corticostriatal glutamatergic excitatory synaptic potentials in both spiny neurons and LA interneurons. Activation of group I mGluRs by the selective agonist 3,5-DHPG produced no detectable effects on membrane properties and glutamatergic synaptic transmission in spiny neurons while it caused a slow membrane depolarization in LA interneurons coupled to increased input resistance. In combined electrophysiological and microfluorometric recordings, 3,5-DHPG strongly enhanced membrane depolarizations and intracellular Ca2+ accumulation induced by NMDA applications in spiny neurons but not in LA interneurons. Activation of protein kinase C (PKC) by phorbol 12,13-diacetate mimicked this latter action of 3,5-DHPG while the facilitatory effect of 3,5-DHPG was prevented by calphostin C, an inhibitor of PKC. These data indicate that a positive interaction between NMDA receptors and group I mGluRs, via PKC activation, is differently expressed in these two neuronal subtypes. Our data also suggest that differential effects of the activation of group I mGluRs, but not of group II and III mGluRs, might partially account for the selective vulnerability to excitotoxic damage observed within the striatum.

References (76)

  • Y. Kawaguchi et al.

    Striatal interneurons: Chemical, physiological and morphological characterization

    Trends Neurosci.

    (1995)
  • J.A. Kerner et al.

    Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus

    Mol. Brain Res.

    (1997)
  • T. Kita et al.

    Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation

    Brain Res.

    (1984)
  • S.R. Lapper et al.

    Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat

    Neuroscience

    (1992)
  • R.L. Martin et al.

    The early events of oxygen and glucose deprivation: Setting the scene for neuronal death

    Trends Neurosci.

    (1994)
  • B. Meldrum et al.

    Excitatory amino acid and neurotoxicity and neurodegenerative disease

    Trends Pharmacol. Sci.

    (1990)
  • S. Nakanishi

    Metabotropic glutamate receptors: synaptic transmission, modulation and plasticity

    Neuron

    (1994)
  • J.P. Pin et al.

    Neurotransmitter receptors. I. The metabotropic glutamate receptors: Structure and functions

    Neuropharmacology

    (1995)
  • A. Pisani et al.

    Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse

    Neuropharmacology

    (1997)
  • J.C. Reubi et al.

    Glutamate release in vitro from corticostriatal terminals

    Brain Res.

    (1979)
  • M. Sorimachi et al.

    Choline uptake by nerve terminals: A sensitive and a specific marker of cholinergic innervation

    Brain Res.

    (1974)
  • H.J. Spencer

    Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: Evidence for glutamic acid as an excitatory transmitter in the striatum

    Brain Res.

    (1976)
  • S.J. TalLaksen-Greene et al.

    Localization of mGluRs1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons

    Brain Res.

    (1998)
  • N.J. Woolf et al.

    Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: A combined Evans blue and acetylcholinesterase analysis

    Brain Res. Bull.

    (1981)
  • F. Nicoletti et al.

    Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders

    Trends Neurosci.

    (1996)
  • M.F. Beal et al.

    Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

    Nature

    (1986)
  • M.F. Beal

    Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness

    Ann. Neurol.

    (1992)
  • P. Calabresi et al.

    Endogenous Ach enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation

    Eur. J. Neurosci.

    (1998)
  • P. Calabresi et al.

    Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses

    J. Neurosci.

    (1997)
  • P. Calabresi et al.

    Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease

    Ann. Neurol.

    (1998)
  • P. Calabresi et al.

    Kainic acid on neostriatal neurons intracellularly recorded in vitro: elctrophysiological evidence for differential neuronal sensitivity

    J. Neurosci.

    (1990)
  • P. Calabresi et al.

    Vulnerability of medium spiny striatal neurons to glutamate: Role of Na+/K+ ATPase

    Eur. J. Neurosci.

    (1995)
  • P. Calabresi et al.

    Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons

    J. Neurosci.

    (1997)
  • P. Calabresi et al.

    Long-term synaptic depression in the striatum: physiological and pharmacological characterization

    J. Neurosci.

    (1992)
  • P. Calabresi et al.

    Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis

    J. Neurophysiol.

    (1990)
  • P. Calabresi et al.

    Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis

    J. Neurophysiol.

    (1990)
  • P. Calabresi et al.

    Long-term potentiation in the striatum is unmasked by removing the voltage-dependent blockade of NMDA receptor channel

    Eur. J. Neurosci.

    (1992)
  • Cited by (98)

    • Glutamate receptor endocytosis and signaling in neurological conditions

      2023, Progress in Molecular Biology and Translational Science
    • Metabotropic glutamate receptors and neurodegenerative diseases

      2017, Pharmacological Research
      Citation Excerpt :

      Inhibition of presynaptic glutamate release through activation of Group II and III mGluRs has been proposed as a potential strategy to limit excitotoxicity. In the striatum, Group II and III mGluRs are mainly located on corticostriatal presynaptic terminals, mediating a negative feedback control for glutamate release [218,245,246]. Importantly, R6/2 HD transgenic mice treated with the mGluR2/3 agonist LY379268 (1.2 mg/kg VO) exhibited increased survival time (about 10% increase) and diminished early pathological hyperactivity, although rotarod deficit and htt intranuclear inclusions were not ameliorated by LY379268 treatment [213].

    • Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII

      2015, Brain Research
      Citation Excerpt :

      This CaMKII-dependent mGluR5-NMDAR coupling is in accordance with the observations that (1) DHPG activated CaMKII in striatal and hippocampal neurons (Choe and Wang, 2001; Mockett et al., 2011; Jin et al., 2013b; this study), (2) Ca2+ or DHPG readily recruited active CaMKII to GluN2B (Leonard et al., 1999; Colbran, 2004; Bayer et al., 2006; Jin et al., 2013b), and (3) mGluR5 signals enhanced phosphorylation of GluN2B at S1303 (Jin et al., 2013b; this study), a CaMKII-sensitive site where phosphorylation augmented NMDAR currents (Liao et al., 2001). Of note, protein kinase C (PKC), an effector downstream to the mGluR5-diacylglycerol pathway, also phosphorylates NMDAR subunits at multiple sites including S1303 (Omkumar et al., 1996; Tingley et al., 1997; Liao et al., 2001) and contributes to the mGluR5 potentiation of NMDAR activity (Pisani et al., 1997; Calabresi et al., 1999). It is therefore likely that CaMKII and PKC act in concert to connect mGluR5 to NMDARs to control synaptic transmission.

    • The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease

      2015, Neurobiology of Disease
      Citation Excerpt :

      Neuropathological analysis reveals selective and progressive neuronal loss in the striatum (DiFiglia, 1990; Vonsattel et al., 1985). Glutamate-mediated neurotoxicity has been postulated to play an important role in the pathogenesis of HD (Anborgh et al., 2005; Calabresi et al., 1999; DiFiglia, 1990; Ribeiro et al., 2010). Stimulation of metabotropic glutamate receptor 5 (mGluR5) leads to the formation of inositol 1,4,5-trisphosphate (InsP3) and release of intracellular Ca2 + and mutant htt can enhance this cell signaling pathway, leading to toxic levels of intracellular Ca2 + (Ribeiro et al., 2010; Tang et al., 2005; Tang et al., 2003).

    View all citing articles on Scopus
    View full text